Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of carfilzomib, including
measuring the amount of the study drug in the blood at certain times following dosing. This
study is being done in people with varying degrees of liver function to see if they respond
differently to the study drug.